Inhibition Function of Dominant-negative Mutant Gene Survivin-D53A to SPC-A1 Lung Adenocarcinoma Xenograft in Nude Mice Models.
- Author:
Min YU
;
Xingchen PENG
;
You LU
;
Meijuan HUANG
- Publication Type:Journal Article
- MeSH:
Adenocarcinoma;
pathology;
Animals;
Apoptosis;
Apoptosis Regulatory Proteins;
metabolism;
Cell Line, Tumor;
Cell Proliferation;
Heterografts;
Humans;
Inhibitor of Apoptosis Proteins;
metabolism;
Liposomes;
Lung Neoplasms;
pathology;
Mice;
Mice, Nude;
Neoplasm Proteins;
metabolism;
Neoplasm Transplantation;
Plasmids;
Transfection;
Tumor Burden
- From:
Journal of Biomedical Engineering
2015;32(3):624-628
- CountryChina
- Language:Chinese
-
Abstract:
Survivin-D53A (SVV-D53A) is a dominant-negative mutant survivin, which represents a potential promising target for cancer gene therapy. The present study was designed to determine whether SVV-D53A plasmid encapsuled by DOTAP: Chol liposome would have the anti-tumor activity against SPC-A1 lung adenocarcinoma, and to detect the possible mechanisms. In our experiment, SPC-A1 cells were transfected in vitro with SVV-D53A plasmid and examined for protein expression by Western blot, then flow cytometric analysis was used to detect apoptosis. SPC-A1 lung adenocarcinoma xenografts were established in vivo in the nude mice, which received the i. v. administrations of SVV-D53A plasmid/liposome complexes. After mice were sacrificed, the paraffin-embedded tumor tissue sections were used for proliferating cell nuclear antigen (PCNA) expression and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Compared with the control group, the mice treated with SVV-D53A plasmid had an obviously reduced tumor volume, with high level of apoptosis and decreased cell proliferation in tumor tissue. The research results proved that the administration of SVV-D53A plasmid resulted in significant inhibition of SPC-A1 cells both in vitro and in vivo. The functional mechanism is that the anti-tumor response causes and induces tumor cell apoptosis.
